FRNM
Freenome, Inc. Health Care Services-Medical Laboratories Russell 3000
$12.48Close
$9.99 – $17.1152-week range
Nov 10, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 2 of 8 trend conditions
- Far from its high 27% below its 52-week high
- Results soon Nov 10, 2026, in 9 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
27%
1wk
down 2.3%
price change
1mo
down 20.8%
price change
12-month return
up 17%
market up 11% ·
its own up 6%
F-score
—
— Not assessed
Altman Z″
-1.36
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
—
year on year
EPS growth
—
latest quarter
Sales growth
—
latest quarter
ROE
—
return on equity
Free cash margin
—
-$864,653 FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
7.9%
$0.99 a day · 2×ATR $10.50
RS
60 / 99
vs the universe
Trend
2 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
1.20
50 sessions
Implied move
—
no option chain · report Nov 10, 2026
Trend template · 2 of 8
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Liabilities exceed assets Shareholders' equity is negative at -$4.8M as of Dec 31, 2025. What is left for shareholders after creditors is, on the balance sheet, less than nothing.
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Profit not backed by cash Reported profit of $837,468 came with -$864,653 of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
Last shock
Oct 12, 2026-16% in one session1.8× volumeno filing matched-6% since
Financials
| FY2025Dec 31, 2025 | |
|---|---|
| Operating income | -$3.0M |
| Net income | $837,468 |
| Free cash flow | -$864,653 |
| Cash | $865,031 |
| Shareholders' equity | -$4.8M |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Jul 15, 2026 | Quarterly ↗ | Jun 30, 2026 | 15d |
| May 13, 2026 | Quarterly ↗ | Mar 31, 2026 | 43d |
| Mar 12, 2026 | Annual ↗ | Dec 31, 2025 | 71d |
| Nov 13, 2025 | Quarterly ↗ | Sep 30, 2025 | 44d |
| Aug 13, 2025 | Quarterly ↗ | Jun 30, 2025 | 44d |
| May 12, 2025 | Quarterly ↗ | Mar 31, 2025 | 42d |
| Mar 19, 2025 | Annual ↗ | Dec 31, 2024 | 78d |
| Nov 13, 2024 | Quarterly ↗ | Sep 30, 2024 | 44d |
| Aug 14, 2024 | Quarterly ↗ | Jun 30, 2024 | 45d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 20, 2026 | Regulation FD · Other events ↗ |
| Jul 27, 2026 | Regulation FD · Other events ↗ |
| Jul 24, 2026 | Material agreement · Acquisition or disposal · Unregistered share sale · Holder rights changed · Auditor change · Change of control · Director or officer change · Charter or bylaws · Item 5.05 · Item 5.06 · Regulation FD · Other events ↗ |
| Jul 15, 2026 | Shareholder vote ↗ |
| Jul 9, 2026 | Other events ↗ |
| Jun 18, 2026 | Regulation FD ↗ |
| Jun 10, 2026 | Charter or bylaws · Shareholder vote ↗ |
| Dec 5, 2025 | Material agreement · Unregistered share sale · Regulation FD ↗ |
| Jun 20, 2024 | Other events ↗ |
| Jun 13, 2024 | Material agreement · Unregistered share sale · Charter or bylaws · Other events ↗ |